Soleus Capital Management, L.P. Axonics, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $2.28 Million - $2.79 Million	-54,089 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $186,860 - $269,950	5,289 Added 10.84%	54,089 $2.76 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $325,322 - $565,586	-14,200 Reduced 22.54%	48,800 $1.71 Million
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $1.04 Million - $2.38 Million	63,000 New	63,000 $1.6 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.